NCT06544629Recruiting
Imjudo & Imfinzi PMS
Imjudo & Imfinzi Post-Marketing Surveillance
Source: ClinicalTrials.gov · Last updated 5 Oct 2026
Brief summary (registry, in English)
Based on the re-review of new drugs article, Korean pharmaceutical act, the objectives of this study are to assess safety and effectiveness of the study drugs(Imjudo \& Imfinzi) in a real world setting in patients who treated according to the approved indications in Korea.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 246 (estimated)
- First submitted
- 6 Aug 2024
- Start date
- 14 Apr 2025
- Primary completion date
- 30 Dec 2029
- Lead sponsor
- AstraZeneca
- NCT number
- NCT06544629
What you commit to
- Study type: Observational
- Planned participants: 246
- From 14 Apr 2025 to the primary completion date, 30 Dec 2029
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Other off-label indications according to the approved label in South Korea
- Current participation in any interventional trial
Who the study is looking for
- Patients eligible for the study drugs according to the approved label in Korea
- Provision of signed and dated written informed consent by the patient or legally acceptable representative
Sex: All · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Busan | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Goyang | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Seongnam | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Suwon | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.